REVINTY ELLIPTA

This brand name is authorized in Austria, Croatia, Estonia, France, Germany, Ireland, Italy, Lithuania, Poland, South Africa, Spain.

Active ingredients

The drug REVINTY ELLIPTA contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII JS86977WNV - FLUTICASONE FUROATE
 

Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action.
 
Read more about Fluticasone furoate
2
UNII 40AHO2C6DG - VILANTEROL TRIFENATATE
 

Vilanterol is a selective long-acting, beta2-adrenergic agonist (LABA). The pharmacologic effects of beta2-adrenoceptor agonist active substances, including vilanterol, are at least in part attributable to stimulation of intracellular adenylate cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.
 
Read more about Vilanterol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 REVINTY ELLIPTA Inhalation powder, pre-dispensed MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AK10 Vilanterol and fluticasone furoate R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 10417646, 10417675, 10417681, 10417698, 16741307, 16741313, 16868781, 16868798, 17510857, 17510863, 17623805, 17867789
EE Ravimiamet 1646962, 1646973, 1646984, 1646995, 1647008, 1647019
ES Centro de información online de medicamentos de la AEMPS 114929002, 114929005
FR Base de données publique des médicaments 64050311, 68680154
IT Agenzia del Farmaco 043446018, 043446020, 043446032, 043446044, 043446057, 043446069
LT Valstybinė vaistų kontrolės tarnyba 1073906, 1073907, 1073908, 1073909, 1073910, 1073911
PL Rejestru Produktów Leczniczych 100323094, 100323102
ZA Health Products Regulatory Authority 48/21.5.1/0247, 48/21.5.1/0248

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈